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The use of electronic alerts in primary care computer systems
to identify the excessive prescription of short-acting beta2-
agonists for people with asthma: a systematic review
Shauna McKibben 1, Anna De Simoni1, Andy Bush2, Mike Thomas3 and Chris Griffiths1
Computers are increasingly used to improve prescribing decisions in the management of long-term conditions however the effects
on asthma prescribing remain unclear. We aimed to synthesise the evidence for the use of computerised alerts that identify
excessive prescribing of short-acting beta2-agonists (SABAs) to improve asthma management for people with asthma. MEDLINE,
CINAHL, Embase, Cochrane and Scopus databases (1990–2016) were searched for randomised controlled trials using electronic
alerts to identify excessive prescribing of SABAs for people with asthma in primary care. Inclusion eligibility, quality appraisal
(Cochrane risk of bias tool) and data extraction were performed by two independent reviewers. Findings were synthesised
narratively. A total of 2035 articles were screened and four trials were eligible. Three studies had low risk of bias: one reported a
positive effect on our primary outcome of interest, excessive SABA prescribing; another reported positive effects on the ratio of
inhaled corticosteroid (ICS)-SABA prescribing, and asthma control; a third reported no effect on outcomes of interest. One study at
high risk of bias reported a reduction in exacerbations and primary care consultations. There is some evidence that electronic alerts
reduce excessive prescribing of SABAs, when delivered as part of a multicomponent intervention in an integrated health care
system. However due to the variation in health care systems, intervention design and outcomes measured, further research is
required to establish optimal design of alerting and intervening systems.
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INTRODUCTION
Asthma affects an estimated 300 million individuals worldwide
and almost 30 million people below 45 years of age in Europe.1
With a prevalence of 6% in 2016–20172 and an estimated 5.4
million people receiving treatment,3 asthma is the most common
long-term condition in the United Kingdom (UK).4 In 2015-2016
there were approximately 1.4 million hospital admissions for
asthma in England and Wales5 and whilst the number of asthma
deaths has fallen by five percent from 2015 to 2016, this remains
higher than the 15-year average.6
The National Review of Asthma Deaths (NRAD) identified that,
of 195 deaths from asthma between 2012 and 2013, 39% of those
who died were prescribed more than 12 short-acting beta2-
agonist inhalers (SABAs) in the previous year, with 4% prescribed
more than 50 SABAs in the same time period.7
Frequent use of SABAs is an internationally recognised marker
of poor control8 and a potentially modifiable warning sign of
impending serious asthma attacks9–12 and asthma death.13–17
Asthma control is defined as the extent to which the manifesta-
tions of asthma, commonly wheeze, shortness of breath, chest
tightness, cough and variable expiratory airflow limitation, can be
observed in the patient, or have been reduced or removed by
treatment.18,19 Control can be assessed by current symptoms and
future risk of adverse outcomes;8 patients with good asthma
control have less need for SABAs and require no emergency
visits.20 Following the National Review of Asthma Deaths, the
electronic surveillance of prescription refill frequency was
recommended to alert clinicians to people with asthma prescribed
excessive quantities of SABAs.7
General practice computer systems increasingly use reminders
and alerts for preventative care and disease management21,22
including asthma.23,24 Computer decision support systems
(CDSSs), defined as ‘active knowledge systems which use two or
more items of patient data to generate case-specific advice,’25
have the potential to influence prescribing behaviour. Efforts to
automate reminder systems and improve efficiency in both
prevention and chronic disease management have yielded some
improvements when assessed using randomised trials.26 However,
evaluations suggest CDSSs do not consistently improve prescrib-
ing behaviour and clinical outcomes27 and the role of electronic
alerts to identify and reduce excessive SABA prescribing remains
unclear. This review aims to provide a systematic overview of the
extent to which electronic alerts in primary care computer systems
can identify excessive prescribing of SABAs, and assess the impact
of these interventions on SABA prescribing, asthma management
and asthma control.
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RESULTS
Study selection
Fig. 1 details the systematic search and eligibility assessment.
From 2035 titles, four studies were selected as eligible.28–31 No
ongoing or unpublished trials were identified. Risk of bias is
reported in Table 1.
Study characteristics
RCTs were conducted between 2001 and 2015; two recent studies
(published in 2014 and 2015) were carried out within integrated
healthcare systems in the United States30 and Canada31 respec-
tively, whilst two older studies were from the United Kingdom
(published in 2001 and 2002).28,29 The features of interventions are
summarised in Table 2. A detailed description of the interventions
can be found in Supplementary Appendix 1. Methods of alerting
included computerised prompts,28,29 an electronic message to
physicians30 and a dashboard alert.31 Three of the four studies
included people with asthma under-18 years of age, of which the
lower age range for inclusion was 5 years of age,31 12 years of
age30 and one not reported.28 No studies stratified findings by age
range. The characteristics of studies are presented in Table 3.
Primary outcome
A brief summary of findings is presented in Table 4. A detailed
description of findings can be found in Table 5.
Study-defined excessive SABA prescribing. Zeiger et al.30 reported
a reduction in the number of patients being dispensed excessive
SABAs (p= 0.007) and an increase in length of time between SABA
prescriptions (p= < 0.001). These effects were noted in the
subgroup of patients without prior asthma specialist care who
received the intervention (p= < 0.001). Tamblyn et al.31 reported
excessive SABA (expressed as fast-acting b-agonist) dispensing as
a composite primary outcome – the rate of out-of-control asthma
episodes–which included emergency department (ED) atten-
dances and hospitalisations. It was therefore not possible to
determine the effect of the intervention on SABAs alone.
Secondary outcomes
SABA prescribing. Zeiger et al.30 reported a reduction in the
number of SABAs dispensed at 3 months (p= < 0.001), 6 months
(p= < 0.001) and 12 months (p= < 0.001) in the subgroup of
patients without prior specialist asthma care. Eccles et al.29
reported no significant effect of a computerised decision support
system on SABA prescription in the 12 months before and after
the intervention (odds ratio (OR) 1.04, 95% CI 0.83–1.31).
ICS prescribing. Zeiger et al.30 reported no difference in the
number of patients dispensed ICS (not as a combination inhaler),
whilst Eccles et al.29 reported no difference in the number of
patients prescribed ICS before and after the intervention.
McCowan et al.28 reported no between-group difference in
maintenance prescribing patterns and no difference in the
proportion of patients classified by management step.
Ratio of ICS-SABA prescribed. Tamblyn et al.31 reported an
increase in the ratio of ICS-SABAs dispensed (mean difference
(MD) 0.27, p= 0.03; 95% CI 0.02–0.51) with higher ratios reported
in both subgroups of patients whose asthma was controlled and
out of control at the start of the study. Zeiger et al.30 reported a
controller (ICS) to total medication ratio of greater or equal to 0.5
at 3, 6 and 12 months, in particular for those without prior asthma
specialist care. As the ICS to total medication ratio was calculated
by the number of ICS canisters or 30-day supplies of oral controller
medications dispensed, divided by the total number of controller
Fig. 1 PRISMA flow chart
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units and SABA inhalers, it was not possible to determine the ICS-
SABA ratio specifically.
ICS/LABA prescribing. Zeiger et al.30 reported an increase in the
number of patients in the subgroup without prior asthma
specialist care dispensed an ICS-LABA inhaler at 3 months (p=
0.004), 6 months (p= < 0.001) and 12 months (p= 0.03).
Asthma reviews. McCowan et al.28 reported no reduction in the
number of patients attending practice-initiated asthma reviews.
Study-defined asthma exacerbations. McCowan et al.28 observed
a reduction in asthma exacerbations, with 8% of patients who
received the intervention reporting an acute asthma exacerbation
compared to 17% in the control group (OR 0.42; 95% CI 0.21-0.85).
However, there was no difference in the use of oral steroids to
manage these attacks in the intervention and control group.
Zeiger et al.30 reported no difference in the numbers of patients
prescribed oral steroids for an exacerbation irrespective of prior
asthma specialist care status. Neither McCowan et al.28 nor Zeiger
et al.30 explicitly defined an asthma exacerbation. Eccles et al.29
reported no difference in the numbers of patients prescribed oral
steroids before and after the intervention but did not specifically
report asthma exacerbations.
Unscheduled consultations for asthma. Eccles et al.29 found no
between-group reduction in the number of primary care asthma
consultations, whilst McCowan et al.28 reported that patients who
received the intervention initiated fewer primary care consulta-
tions (OR 0.59; 95% CI 0.37–0.95). However neither study clarified
whether consultations were scheduled or unscheduled. Both
McCowan et al.28 and Zeiger et al.30 reported no effect of the
intervention on ED attendances or hospitalisations for asthma.
Tamblyn et al.31 reported ED visits and hospitalisations for asthma
as a composite outcome defined as ‘rate of out-of-control asthma
episodes,’ therefore secondary care consultations for asthma
could not be specifically determined.
Asthma control. Tamblyn et al.31 reported a reduction in the rate
of out-of-control asthma events, defined as a composite outcome
of excessive SABA use, ED attendance and hospitalisations for
asthma, in the sub-group of patients whose asthma was out-of-
control at the beginning of the study (MD −28.4, p= 0.04; 95% CI
−55.6, −1.2). When stratified by intervention component, the rate
of out-of-control asthma events further reduced when patients
were treated with CDSS alone (rate difference (RD) −36.9/100 per
year, p= 0.01) in comparison to those threated with both CDSS
and the asthma home care monitoring programme (RD -28.4, p=
0.04; 95% CI −55.6,−1.2).
DISCUSSION
Main findings
Given the few studies identified, the evidence to support the use
of alerts to reduce excessive SABA prescribing in primary care is
limited but promising. This review found that electronic alerts,
when delivered as a multicomponent intervention in an inte-
grated health care system, have the potential to successfully
identify and reduce excessive SABA prescribing. The greatest
effect on our outcomes of interest occurred when an alert,
delivered in an integrated health care system, flagged excessive
SABA prescribing to clinicians and prompted/facilitated interven-
ing actions including referral to an allergy specialist and a patient
information letter.30 None of the studies included used a SABA
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Interpretations in relation to published literature
Our findings support previous research on the use of computer
decision support for long-term conditions including asthma,
chronic obstructive pulmonary disease, diabetes and osteoporosis
which found that interventions consisting of multiple components
are associated with greater improvement in outcomes than single-
target interventions with fewer components.24,32,33
There is however no consensus definition on excessive SABA
use in the literature. Definitions of excessive SABA use vary from
three or more SABAs per quarter34 to 12 or more SABAs a year.7 Of
the two included studies in which excessive SABA use was
reported, definitions varied from greater or equal to seven
canisters per year (at least four puffs per day per year)30 to
greater than 250 doses of SABA in the past 3 months.31
The identification and reduction of excessive SABA use in Zeiger
et al.30 study was facilitated by alerts that were not restricted to
point-of-care presentation. Such methods of alerting may offer a
solution to the dilemma that automatic provision of decision
support at point of decision making neither guarantees clinician
uptake or engagement27 nor predicts improvements in process of
care or patient outcomes.35 The two studies that showed greatest
effects on our outcomes of interest were those carried out recently
(in the past three years), in which decision support was integrated
with electronic health record (EHRs).30,31 Although research has
indicated that advice presented within EHRs is less likely to
improve care or outcomes than stand-alone programmes,35 our
findings support the evidence that computer decision support
integrated with clinician workflow is associated with improved
outcomes.22,32 Zeiger et al’s finding of a reduction of excessive
SABA use supports the evidence that electronic health records and
electronic messaging in an integrated health care system
increases clinician adherence to evidence-based guidelines.36
In one study, users failed to engage with decision support29
whilst in another, clinicians failed to interact with the CDSS in
approximately 60% of cases.31 However it is not clear whether
levels of engagement were consistent between clinicians and
whether clinician interaction declined over time. There may be
valid reasons to account for the variability in decision support
engagement which include technical design of the CDSS, the
setting in which the system is deployed and the characteristics of
users and the patients treated.27 The higher user engagement in
Tamblyn et al.31 is likely due to the increased ease of use
associated with more recent, sophisticated decision support
integrated within a comprehensive EHR system that accesses
pharmacy, as well as primary and secondary care data. This is in
comparison to older interventions, such as that of Eccles et al.29
where the intervention was not integrated with the EHR, and in
which pharmacy and secondary care data was not captured.
Alerts integrated within EHRs may interrupt clinician workflow
and result in “alert fatigue” with up to 96% of alerts over ridden or
ignored in one study.37 Following user feedback, Eccles et al.29
altered decision support to trigger when a clinician entered a
relevant morbidity code rather than being automatically activated
upon entering a patient’s medical record. Whilst this may have
been an attempt to minimise alert fatigue it did not improve CDSS
user interaction. It is likely that very low CDSS interactions
reflected clinical guidelines being located in a separate system not
supported within clinician workflow.
Qualitative research used in conjunction with RCTs has the
potential to beneficially influence intervention design and
delivery38 however none of the included studies reported using
qualitative methods to complement intervention design. Such
methods may optimise alert design, improve clinician interaction
with decision support and aid the interpretation of results.
Strength and limitations
As interventions to improve prescribing volumes/rates do not
necessarily result in more ‘appropriate’ prescribing or improved
patient outcomes27 both process and clinical outcomes were
assessed in this review. However few studies met our inclusion
criteria, with only one study reporting our primary outcome of
interest. Due to the limited number of published reports of
randomised controlled trials in our analyses, there may be
possibility of publication bias or selective reporting. Interventions
in the two older studies28,29 were poorly described which may
have limited our interpretation of the findings. We were unable to
conduct a meta-analysis due to heterogeneity in intervention
design and outcomes evaluated. Due to a lack of reporting no
conclusions could be made on health economics.
Implications for clinical care and future research
There is an increased focus on the digitalisation of the NHS in an
attempt to improve safety and quality of care.39 Recommenda-
tions have called for the national use of electronic alerts to identify
excessive prescribing of SABAs in the UK.7,40 Due to the few
studies identified in this review, the role of alerts to reduce
excessive SABA prescribing in the UK’s publically funded national
health service (NHS) remains unclear. Integrated care can take
many forms involving collaboration between policy providers and
commissioners and between service providers, however benefits
arise primarily when clinical teams and services are brought
together and incentives are aligned to support service improve-
ment.36 It is likely that a combination of design, technical
capabilities and variety of intervention components, when
delivered in an integrated health care system, facilitated the
improvements to SABA prescribing and asthma management
identified in recent studies. In a publicly funded health care
system such as the NHS it remains challenging to deliver such
improvements. However this review identifies a number of areas
where potential exists and where further research is
recommended.
In the UK, 78% of bronchodilators are issued on repeat
prescription41 yet research fails to address the use of alerts at
this point in the prescribing process. Furthermore, two studies
from the UK, carried out over a decade ago, did not integrate
interventions within EHRs, in contrast to more recent studies from
North America. Future research should consider novel ways to
Table 2. Summary of intervention features
Features in addition to alert McCowan et al.28 Eccles et al.29 Zeiger et al.30 Tamblyn et al.31
Guideline decision support   
Allergy Specialist Referral 
Specialist asthma nurse home-care monitoring 
Self-management plan  
Patient advice sheet  
Patient information letter 
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deliver SABA alerts as a sole intervention and/or as part of a
multicomponent intervention in primary care. Furthermore, the
point in the prescribing process at which a SABA alert will have
greatest impact should be explored. Interventions should be
trialled both in and outside of the consultation to target clinicians
and people with asthma.
Standardised methods for the design and reporting of CDSS
interventions are recommended to enable a thorough evaluation
of process and clinical outcomes. We support previous recom-
mendations that studies use a taxonomy or framework such as
Kawamoto et al.21 and Berlin et al.42 to theoretically underpin the
design and reporting of interventions.25,43 An explicitly defined
outcome set that includes more standardised endpoints, e.g.,
excessive SABA prescribing and asthma exacerbations, may help
the translation of research findings into clinical practice. We
recommend that future studies report on both the implementa-
tion process and health economics outcomes associated with
CDSS-based alerts. Third party external validation of CDSSs is
recommended.35 Systems evaluation involving academic-
commercial collaborations and user testing should be explored
to aid the translational research process. End-users should be
involved in the design of alerts to optimise interventions and trial
design. Future studies should consider mixed methods designs
that incorporate qualitative methods before, during and/or after
an RCT. Such methods may help determine the barriers and
facilitators to alert usage in practice, as well as assisting in the
development of alerts that are transferable to the real-world
clinical setting.
CONCLUSION
There is some evidence that electronic alerts integrated with EHRs
and delivered as part of a multicomponent intervention reduce
excessive SABA prescribing. Due to variations in health care
systems, intervention designs and outcomes measured, further
research is required to determine the effects of alerts on excessive
SABA prescribing in a publically funded health system. Future
research should determine the point at which novel alerts will
most effectively reduce excessive SABA prescribing and be
accepted by users.
MATERIALS AND METHODS
The study design was a systematic review, performed following
PRISMA-guidelines.44 Methods of analysis and inclusion criteria
were specified in advance and documented in a protocol45 and
registered on PROSPERO (International Prospective Register of
Systematic Reviews; www.crd.york.ac.uk/PROSPERO/) with identi-
fier CRD 42016035633.
Selection criteria
Studies were considered for inclusion in this systematic review
according to the following criteria.
Participants. Studies that delivered care to adults and/or children
with asthma, in a primary care setting. Primary care was defined as
healthcare delivered in a community setting, most commonly in
general practice, by a clinician, nurse or pharmacist. Non-clinical
staff for example administrators and/or receptionists were also
included.
Intervention. CDSSs were included if they incorporated an alert
initiated by the excessive prescribing or dispensing of SABAs for
asthma. Alerts used in secondary or tertiary care, for other
respiratory conditions that were not asthma were excluded.
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Outcomes. Our primary outcome of interest was excessive SABA
prescribing. Excessive prescribing of SABA was assessed on a
study-defined basis. Secondary outcomes of interest included
additional measures of prescribing and process of care (future
SABA and ICS prescribing, ICS/SABA prescribing ratio, ICS/long-
acting beta2-agonist prescribing (LABA), asthma reviews), and
clinical outcomes (asthma exacerbations with/without oral ster-
oids, unscheduled primary and secondary care asthma consulta-
tions, asthma control).
Study design. Only randomised controlled trials (RCTs), in any
language, were included as they are considered the most rigorous
way to evaluate intervention effectiveness.46
Search strategy
We searched Medline, Embase, Cinahl, Scopus and Cochrane
Library databases from 1990 to 2016 with the search terms listed
in Supplementary Appendix 2. We contacted the authors of
included studies to clarify intervention design and outcomes
measured where necessary. Ongoing and unpublished trials were
searched for using the following websites: https://www.isrctn.
com/ and https://clinicaltrials.gov/.
Two authors (SM and CG) independently screened titles and
abstracts, assessing them against the inclusion criteria. Both
authors reviewed the full text of each potentially eligible paper to
determine suitability for inclusion. Disagreements were resolved
by discussion and, if necessary, arbitration of a third researcher
(ADS, AB, MT).
Data extraction and quality appraisal
Using a piloted data extraction form, SM and ADS independently
extracted the following data from included trials: country, setting,
funding, study design, healthcare professional and patient
population, features of the CDSS intervention, description of the
control group, outcome measures, results and risk of bias
assessment. SM and ADS compared data extraction, and
disagreements were arbitrated by a third researcher (CG) if
necessary.
We assessed the risk of bias in each trial using the seven-criteria
approach described in section eight of the Cochrane Handbook
for Systematic Reviews of Interventions.47
Data analysis
Due to heterogeneity in the CDSS interventions used and in
outcomes measured, we undertook a narrative synthesis.
Data availability
Authors confirm that all relevant data are included in the paper
and/or its supplementary information files.
ACKNOWLEDGEMENTS
The authors wish to thank Asthma UK and Queen Mary University London for funding
this work as part of a PhD studentship carried out by S.M. A.D.S. is funded by a NIHR
Academic Clinical Lectureship. A.B. is a National Institute for Health Research (NIHR)
Senior Investigator and additionally was supported by the NIHR Respiratory Disease
Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust
and Imperial College London. M.T. is supported by the NIHR Collaboration for
Leadership in Applied Health Research and Care (CLAHRC) Wessex, NIHR School of
Primary Care Research and NIHR Southampton Biomedical Research Centre. C.G. is
supported by the NIHR CLAHRC North Thames at Bart’s Health NHS Trust. The views
expressed are those of the author(s) and not necessarily those of the NHS, the NIHR
or the Department of Health. This work is funded by Asthma UK and Queen Mary
University of London.
AUTHOR CONTRIBUTIONS
This work forms part of an Asthma UK Centre for Applied Centre PhD Studentship
being undertaken by S.M. C.G. had the original idea for the study. S.M., A.B., M.T. and
C.G. contributed to the plan and/or design of the study. S.M. and C.G. completed
study screening. S.M. and A.D.S. performed data extraction. S.M. drafted the
manuscript and A.D.S., A.B., M.T. and C.G. commented on each draft version. All
authors read and approved the final manuscript.
ADDITIONAL INFORMATION
Supplementary information accompanies the paper on the npj Primary Care
Respiratory Medicine website (https://doi.org/10.1038/s41533-018-0080-z).
Competing interests: C.G. is an assistant editor of npj Primary Care Respiratory
Medicine and M.T. is an associate editor of npj Primary Care Respiratory Medicine but
were involved in neither the editorial review of, nor any decision to publish or not
publish this article.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims
in published maps and institutional affiliations.
REFERENCES
1. Gibson, J. G., Loddenkemper, R., Lundbäck., B. & Sibille, Y. Respiratory health and
disease in Europe: the new European lung white book. Eur. Respir. J. 42, 559–563
(2013).
2. Health and Social Care Information Centre. Quality and Outcomes Framework-
Prevalence, Achievements and Exceptions Report, England 2016–2017. https://www.
gov.uk/government/statistics/quality-and-outcomes-framework-achievement-
prevalence-and-exceptions-data-2016-to-2017.
3. Asthma U.K. Asthma facts and statistics. https://www.asthma.org.uk/about/media/
facts-and-statistics/.
4. National Institute for Health and Excellence. Asthma Quality Standard (QS25).
https://www.nice.org.uk/guidance/qs25.
5. NHS Digital. Hospital Admitted Patient Care Activity, 2015-16. https://www.gov.uk/
government/statistics/hospital-admitted-patient-care-activity-2015-to-2016.
6. Asthma U.K. Asthma UK calls for action to end preventable asthma deaths.
(2017).
7. Royal College of Physicians. Why Asthma Still Kills-The National Review of Asthma
Deaths (NRAD) Confidential Enquiry report. https://www.rcplondon.ac.uk/projects/
national-review-asthma-deaths (2014).
8. Global Initiative for Asthma. Global Strategy for Asthma Management and Pre-
vention. http://ginasthma.org/2017-gina-report-global-strategy-for-asthma-
management-and-prevention/ (2017).
9. Schatz, M. et al. Asthma quality-of-care markers using administrative data. Chest
128, 1968–1973 (2005).
10. Paris, J. et al. Relationship between recent short-acting beta-agonist use and
subsequent asthma exacerbations. Ann. Allergy Asthma Immunol. 101, 482–487
(2008).
11. Patel, M. et al. Metrics of salbutamol use as predictors of future adverse outcomes
in asthma. Clin. Exp. Allergy 43, 1144–1151 (2013).
12. British Thoracic Society and Scottish Intercollegiate Guidelines Network. British
guideline on the management of asthma: a national clinical guideline. (2016).
13. Spitzer, W. O. et al. The use of beta-agonists and the risk of death and near death
from asthma. N. Engl. J. Med 326, 501–506 (1992).
14. Suissa, S. et al. A cohort analysis of excess mortality in asthma and the use of
inhaled beta-agonists. Am. J. Respir. Crit. Care Med. 149, 604–610 (1994).
15. Suissa, S., Blais, L. & Ernst, P. Patterns of increasing beta-agonist use and the risk
of fatal or near-fatal asthma. Eur. Respir. J. 7, 1602–1609 (1994).
16. Anderson, H. R. et al. Bronchodilator treatment and deaths from asthma: case-
control study. BMJ 330, 117 (2005).
17. Lanes, S. F., Garcia Rodriguez, L. A. & Huerta, C. Respiratory medications and risk
of asthma death. Thorax 57, 683–686 (2002).
18. Reddel, H. K. et al. An official American Thoracic Society/European Respiratory
Society statement: asthma control and exacerbations: standardizing endpoints
for clinical asthma trials and clinical practice. Am. J. Respir. Crit. Care Med. 180,
59–99 (2009).
19. Taylor, D. R. et al. A new perspective on concepts of asthma severity and control.
Eur. Respir. J. 32, 545–554 (2008).
20. Bateman, E. D. et al. Global strategy for asthma management and prevention:
GINA executive summary. Eur. Respir. J. 31, 143–178 (2008).
21. Kawamoto, K., Houlihan, C. A., Balas, E. A. & Lobach, D. F. Improving clinical
practice using clinical decision support systems: a systematic review of trials to
identify features critical to success. BMJ 330, 765 (2005).
The use of electronic alerts in primary care computer
S McKibben et al.
8
npj Primary Care Respiratory Medicine (2018)  14 Published in partnership with Primary Care Respiratory Society UK
22. Pearson, S. A. et al. Do computerised clinical decision support systems for pre-
scribing change practice? A systematic review of the literature (1990-2007). BMC
Health Serv. Res. 9, 154 (2009).
23. Fathima, M., Peiris, D., Naik-Panvelkar, P., Saini, B. & Armour, C. L. Effectiveness of
computerized clinical decision support systems for asthma and chronic
obstructive pulmonary disease in primary care: a systematic review. BMC Pulm.
Med. 14, 189 (2014).
24. Matui, P., Wyatt, J. C., Pinnock, H., Sheikh, A. & McLean, S. Computer decision
support systems for asthma: a systematic review. NPJ Prim. Care Respir. Med. 24,
14005 (2014).
25. Wyatt, J. & Spiegelhalter, D. Field trials of medical decision-aids: potential pro-
blems and solutions. Proc. Annu. Symp. Comput. Appl. Med. Care, 3–7 (1991).
http://www.ncbi.nlm.nih.gov/pubmed/1807610.
26. Black, A. D. et al. The impact of eHealth on the quality and safety of health care: a
systematic overview. PLoS Med. 8, e1000387 (2011).
27. Moxey, A. et al. Computerized clinical decision support for prescribing: provision
does not guarantee uptake. J. Am. Med. Inform. Assoc. 17, 25–33 (2009).
28. McCowan, C. et al. Lessons from a randomized controlled trial designed to
evaluate computer decision support software to improve the management of
asthma. Med. Inform. Internet Med. 26, 191–201 (2001).
29. Eccles, M. et al. Effect of computerised evidence based guidelines on manage-
ment of asthma and angina in adults in primary care: Cluster randomised con-
trolled trial. BMJ 325, 941–944 (2002).
30. Zeiger, R. S. et al. Real-time asthma outreach reduces excessive short-acting β2-
agonist use: a randomized study. J. Allergy Clin. Immunol. Pract. 2, 445–456 (2014).
e1–e5.
31. Tamblyn, R. et al. Evaluating the impact of an integrated computer-based deci-
sion support with person-centered analytics for the management of asthma in
primary care: a randomized controlled trial. J. Am. Med. Inform. Assoc. 22, 773–783
(2015).
32. Roshanov, P. S. et al. Computerized clinical decision support systems for chronic
disease management: a decision-maker-researcher partnership systematic
review. Implement Sci. 6, 92 (2011).
33. Kastner, M. & Straus, S. E. Clinical decision support tools for osteoporosis disease
management: a systematic review of randomized controlled trials. J. Gen. Intern
Med. 23, 2095–2105 (2008).
34. Silver, H. S. et al. Quarterly assessment of short-acting β2-adrenergic agonist use
as a predictor of subsequent health care use for asthmatic patients in the United
States. J. Asthma 47, 660–666 (2010).
35. Roshanov, P. S. et al. Features of effective computerised clinical decision support
systems: meta-regression of 162 randomised trials. BMJ 346, f657 (2013).
36. Curry, N. & Ham, C. Clinical and service integration: the route to improved outcomes.
The King’s Fund. http://www.kingsfund.org.uk/publications/clinical-and-service-
integration (2010).
37. van der Sijs, H., Aarts, J., Vulto, A. & Berg, M. Overriding of drug safety alerts in
computerized physician order entry. J. Am. Med Inform. Assoc. 13, 138–147 (2006).
38. Cathain, A., Thomas, K. J., Drabble, S. J., Rudolph, A. & Hewison, J. What can
qualitative research do for randomised controlled trials? A systematic mapping
review. BMJ Open 3, e002889 (2013).
39. Brailer, J. A.-M. et al. Making IT work-harnessing the power of health information
technology to improve care in England. (Department of Health, London, 2016).
40. Asthma U.K. Connected asthma: how technology will transform care. https://www.
asthma.org.uk/connectedasthma (2016).
41. Petty, D. The repeat prescription report. Pharmacy2U. https://www.pharmacy2u.co.
uk/prescription-report.html (2017).
42. Berlin, A., Sorani, M. & Sim, I. A taxonomic description of computer-based clinical
decision support systems. J. Biomed. Inform. 39, 656–667 (2006).
43. Car, J. et al. The Impact of eHealth on the Quality and Safety of Healthcare. A Report
for the NHS Connecting for Health Evaluation Programme: Extended executive
summary (2008).
44. Moher, D. et al. Preferred reporting items for systematic reviews and meta-ana-
lyses: the PRISMA statement. PLoS Med. 6, e1000097 (2009).
45. McKibben, S., Bush, A., Thomas, M. & Griffiths, C. The use of electronic alerts in
primary care computer systems to identify the over-prescription of short-acting
beta2-agonists in people with asthma: a protocol for a systematic review. NPJ
Prim. Care Respir. Med. 27, 30 (2017).
46. Craig, P. et al. Developing and evaluating complex interventions: the new
medical research council guidance. BMJ 337, a1655 (2008).
47. Higgins J. P. T. & Green S. (eds) Cochrane Handbook for Systematic Reviews of
Interventions Version 5.1.0. The Cochrane Collaboration. http://www.cochrane-
handbook.org (2011).
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in anymedium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly
from the copyright holder. To view a copy of this license, visit http://creativecommons.
org/licenses/by/4.0/.
© The Author(s) 2018
The use of electronic alerts in primary care computer
S McKibben et al.
9
Published in partnership with Primary Care Respiratory Society UK npj Primary Care Respiratory Medicine (2018)  14 
